London-based drug maker GlaxoSmithKline PLC said Tuesday it is planning to close one of its English plants, which employs 620 people, by 2013 because the majority of drugs made at the plant are losing their patent protection and facing generic competition within a year.
Copyright PHILY - Philly.com
